123
Participants
Start Date
October 31, 2015
Primary Completion Date
December 31, 2017
Study Completion Date
August 31, 2020
Lenvatinib
Universitätsklinik für Innere Medizin, Graz
Istituto Europeo di Oncologia - Unità di Oncologia Medica Gastrointestinale e Tumori Neuroendocrini, Milan
Hospital Universitario Ramón y Cajal, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario la Paz, Madrid
Hospital Virgen de la Victoria, Málaga
Hospital Central de Asturias, Oviedo
Hospital Marqués de Valdecilla, Santander
AOU Policlinico di Modena - DH Oncologico, Modena
Hospital Miguel Servet, Zaragoza
Azienda Ospedaliero Universitaria Careggi - SC di Oncologia, Florence
Medizinische Universität Wien, Vienna
Spedali Civili di Brescia, Brescia
Instituto Oncologico Mediterraneo, Catania
IRST of Meldola, Meldola
IRCCS Napoli, Napoli
Hospital Universatorio de Verona, Verona
Hospital de Donostia, Donostia / San Sebastian
Hospital Universitario Vall Hebrón, Barcelona
ICO Hospitalet, L'Hospitalet de Llobregat
Beatson Oncology Centre Gartnavel General Hospital, Glasgow
Christie Hospital, Manchester, Manchester
Eisai Limited
INDUSTRY
Experior S.L.
UNKNOWN
Grupo Espanol de Tumores Neuroendocrinos
OTHER